31Indexed trials
mesh condition
Cognition Disorders
Intelligence
Cognition Disorders intelligence: 31 indexed trials, 9 recruiting studies, 28 sponsors across 18 countries.
9Recruiting
28Sponsors
18Countries
Leading sponsors
Eli Lilly and Company21 recruiting
University of Southern California20 recruiting
Federal University of Paraíba21 recruiting
Andreas Monsch10 recruiting
Columbia University10 recruiting
Carelon Research10 recruiting
Emory University11 recruiting
Assistance Publique - Hôpitaux de Paris10 recruiting
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia10 recruiting
HealthPartners Institute10 recruiting
Homewood Research Institute10 recruiting
Alzheimer's Disease Cooperative Study (ADCS)10 recruiting
Geographic activity
United States17trials
Canada4trials
France3trials
Spain2trials
Taiwan2trials
Japan2trials
Brazil2trials
Sweden1trials
Switzerland1trials
Turkey (Türkiye)1trials
United Kingdom1trials
Puerto Rico1trials
Leading interventions
Flortaucipir2trials
Atomoxetine 80 MG1trials
Cognitive Training1trials
Brain Stimulation1trials
Cardiovascular evaluation1trials
Cognitite-motor Dual Task Training (DT training)1trials
BPN147701trials
Cognitive training1trials
Donanemab1trials
Double neuropsychological standard activities1trials
Florbetaben1trials
Active Repetitive Transcranial Magnetic Stimulation (rTMS)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.